One company makes Xanax and Viagra. The other makes the popular EpiPen drug for people with allergies. Now they may be close to merging. One company makes Xanax and Viagra. The other makes the popular ...

Pfizer will merge its off-patent drug business with generic drugmaker Mylan, a move that would create a lower-priced medication powerhouse, according to The Wall Street Journal. The combined company ...

If the merger of Pfizer’s off-patent drug unit and Mylan is approved, Mylan CEO Heather Bresch could earn more than $37.6 million in severance and vested benefits, according to The Pittsburgh Post ...

Pfizer, the country’s largest drugmaker, is creating a hybrid new drug company by combining its off-patent branded drug business with the generic pharmaceutical company Mylan. Pfizer’s Upjohn, which ...

Mylan N.V. and Pfizer Inc. announced a definitive agreement to combine Mylan with Upjohn, Pfizer’s off-patent branded and generic established medicines business, creating a new global pharmaceutical ...

Sources are telling many reporters that Pfizer is close to a deal that would merge its off-patent drugs business with generic-drug maker Mylan to create a huge global entity making and marketing both ...

Pfizer Inc. and two of its subsidiaries have agreed to pay $345 million under a proposed settlement to resolve lawsuits over EpiPen price hikes. In documents filed Thursday in federal court in Kansas ...

INDIANAPOLIS — The state of Indiana is suing two of the world's biggest drug companies over the price of EpiPens. Attorney General Todd Rokita claims that Mylan and Pfizer have conspired to increase ...

First and foremost, Pfizer just confirmed its desire to acquire British pharmaceutical giant AstraZeneca. Pfizer stated that it initially made a bid for AstraZeneca in January, and approached the ...

NEW YORK, March 23 (Reuters) - Mylan Laboratories Inc. said on Friday it launched generic versions of Pfizer Inc.'s blockbuster Norvasc blood-pressure drug, a day after a federal court ruled a Pfizer ...

NEW YORK, Feb 27 (Reuters) - Pfizer Inc. won a U.S. federal patent case against generic drugmaker Mylan Laboratories Inc. over Pfizer's blockbuster Norvasc blood-pressure drug, the companies said on ...

HERTFORDSHIRE, England, PITTSBURGH and NEW YORK, Sept. 15, 2020 /PRNewswire/ -- Mylan (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the companies have received final approval from the ...